Modeling and optimal control of ADE-prone dual-strain influenza: balancing costs, risks, and interventions
Zongmin Yue , Yi Dong , Hui Cao
Electronic Research Archive ›› 2026, Vol. 34 ›› Issue (7) : 4410 -4447.
Antibody-dependent enhancement (ADE) is a major safety challenge in multiserotype disease control, involving complex trade-offs among infection burden, cost, and vaccine safety. This study develops a two-strain influenza model that integrates both host immunity (endogenous) and viral cross-reactivity (exogenous) as dual mechanisms underlying ADE. Threshold analysis shows that exogenous ADE lowers transmission thresholds (eR1, eRA), promoting strain coexistence, whereas endogenous ADE reverses this trend. We further establish a multiobjective optimal control framework to balance outbreak control, ADE risk, and intervention costs. The resulting strategy combines early targeted measures with sustained behavioral precautions (e.g., 51–79% mask-wearing compliance), effectively reducing the peak infection rate. Crucially, we identify an optimal risk-aversion level (α ≈ 2), which halves the ADE risk with only a 2.3% increase in infections and minimal extra cost- demonstrating a clear Pareto-optimal trade-off. This quantitative framework can be applied to other contexts, such as multivalent vaccine design for dengue fever, and provides a decision-making basis for risk-benefit assessment of vaccines against emerging infectious diseases.
antibody-dependent enhancement (ADE) / dual-strain influenza model / basic reproduction number / stability / optimal control
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
WHO, Western Pacific. Available from: https://www.who.int/westernpacific/. |
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
WHO, Influenza (seasonal). Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). |
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
/
| 〈 |
|
〉 |